Treatment of Anxiety and Depression in Pregnancy – What do the Data Tell Us?
Treating anxiety and depression during pregnancy is a complex and crucial aspect of maternal healthcare. There are extensive data available on the safety of anti-anxiety and anti-depressant medications for pregnant women, and registries and database studies also play a role in monitoring drug safety. We caught up with Meg Richards, PhD, MPH, Executive Director, Scientific […]
Emerging Issues in Real-World Evidence: How Observational Studies Can Complement Randomized Controlled Trials
The randomized controlled trial (RCT) forms the cornerstone of drug approval by regulatory agencies, providing robust evidence on the safety and efficacy of new therapies. However, the landscape of clinical research is evolving with the increasing use of real-world evidence (RWE) derived from observational studies utilizing existing healthcare data. This shift is partly driven by […]
Navigating the New IRA Landscape by Leveraging Real-World Evidence
This blog post summarizes remarks given at Panalgo’s Data to Insights 2024 conference in Atlanta on May 9, 2024. Although the impact of the Inflation Reduction Act (IRA) remains uncertain, the new provisions requiring Medicare to negotiate selected drug prices seem highly likely to increase the importance of real-world evidence (RWE). Like it or not, […]
Hot Takes from ‘Hotlanta’ – ISPOR Annual 2024
ISPOR Annual 2024 was held in Atlanta this year and as always, the Congress did not disappoint. Echoes of the 1996 Olympics were in the air while walking into the Georgia World Convention Center through the Olympic Centennial Park, which remains a jewel in that part of the city, complete with Atlanta’s Ferris Wheel take […]
The Road to Analytics Success
For the life sciences industry, harnessing the right data can help companies make better decisions and improve patient outcomes. At “Data to Insights 2024,” Panalgo’s annual conference held in Atlanta last week, industry experts discussed the latest hot topics and shared best practices for harnessing data to make more informed decisions. This year’s road trip-themed […]
Open vs. Closed Claims: Unlocking Opportunities for Healthcare Analytics
In the complex healthcare analytics landscape, understanding the nuances of open and closed claims is critical for researchers and analysts. Open and closed claims each offer unique insights into the patient journey. Open claims, sourced from various clearinghouses and warehouses across the U.S., present a vast collection of data, while closed claims, adjudicated by insurers, […]
How Machine Learning Strengthens Real-World Data and Disease Identification: 5 Use Cases in 5 Minutes
Machine learning is a powerful tool in the life sciences industry, making evidence generation more efficient and precise and bolstering real-world data (RWD) to identify diseases earlier, trigger timely interventions, and recommend screenings and physician referrals. Our blog series, How Life Sciences is Leveraging Machine Learning: 5 Use Cases in 5 Minutes, explores five recent studies […]
What’s next for the life sciences industry? Four trends to watch in 2024
2023 was an eventful year for the life sciences industry, with the Inflation Reduction Act (IRA) and game-changing technology like ChatGPT dominating the headlines. Will biopharma’s constrained budgets, reorganizations, and reductions in force continue in 2024, or will there be a healthy rebound from these prunings? Only time will tell. There are positive developments on […]
Leaning Into RWE: The IRA is Here, So Now’s the Time
Manufacturers are continuing to wrestle with the effects of the Inflation Reduction Act (IRA) on their business plans and revenue streams. Although some of the IRA’s impacts are still uncertain, real-world evidence (RWE) is an important tool for manufacturers in navigating the road ahead, as it will help them demonstrate the value and comparative effectiveness […]
Conclusions from Copenhagen: Highlights of ISPOR EU 2023
ISPOR Europe 2023, with the largest number of delegates on record (5,600) was held in wonderful, wonderful Copenhagen (cue the Danny Kaye waltz) last week. Neither congress nor venue disappointed, and despite leaden skies and gusty rain showers, attendees were able to sample scientific sessions by day and the Christmas Markets by night. The Panalgo […]